Smith-Whitley Kim 4
4 · Global Blood Therapeutics, Inc. · Filed Jun 2, 2021
Insider Transaction Report
Form 4
Smith-Whitley Kim
See Remarks
Transactions
- Award
Restricted Stock Units
2021-06-01+24,160→ 24,160 total→ Common Stock (24,160 underlying) - Award
Stock Option (Right to Buy)
2021-06-01+35,500→ 35,500 totalExercise: $37.20Exp: 2031-05-31→ Common Stock (35,500 underlying) - Award
Restricted Stock Units
2021-06-01+6,300→ 6,300 total→ Common Stock (6,300 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest with respect to 25% of the underlying shares on June 1, 2022 and in six semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F3]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, subject to the Reporting Person's continuous service with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F4]The stock option vests with respect to 25% of the underlying shares on May 3, 2022 and in 12 equal quarterly installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.